*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| Z79811 - Long term (current) use of aromatase inhibitors - as a primary or secondary diagnosis code | ||
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | ||
| Readmission Rate (%) | ||
| Unplanned Readmission Rate (%) | 11.99 | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 1,522,684 | ||||
| Total Hospitalizations with ICD Z79811 - Long term (current) use of aromatase inhibitors | 1,569 | ||||
| DRG Share of Total Hospitalizations | 4.63 | ||||
| % of Total ICD Z79811 - Long term (current) use of aromatase inhibitors in DRG | 7.14 | ||||
| Avg LOS at DRG | 2.52 | ||||
| Avg LOS with ICD Z79811 - Long term (current) use of aromatase inhibitors | 2.56 | ||||
| Readmission Rate at DRG | 9.03 | ||||
| Readmission Rate with ICD Z79811 - Long term (current) use of aromatase inhibitors | 7.68 | ||||
| Unplanned Readmission Rate at DRG | 3.35 | ||||
| Unplanned Readmission Rate with ICD Z79811 - Long term (current) use of aromatase inhibitors | 2.58 | ||||
| Total Medicare payments at DRG | $17,672,828,347 | ||||
| Total Medicare payments with ICD Z79811 - Long term (current) use of aromatase inhibitors | $19,451,040 | ||||
| Total Medicare payment per Day at DRG | $4,606 | ||||
| Total Medicare payment per Day with ICD Z79811 - Long term (current) use of aromatase inhibitors | $4,841 | ||||
| Total Medicare payment per Hospitalization at DRG | $11,606 | ||||
| Total Medicare payment per Hospitalization with ICD Z79811 - Long term (current) use of aromatase inhibitors | $12,397 | ||||
| Total Medicare Charges at DRG | $91,836,200,128 | ||||
| Total Medicare Charges with ICD Z79811 - Long term (current) use of aromatase inhibitors | $96,279,162 | ||||
| Avg Charges at DRG | $60,312 | ||||
| Avg Charges with ICD Z79811 - Long term (current) use of aromatase inhibitors | $61,363 | ||||
| Mortality Rate at DRG | 0.05 | ||||
| Mortality Rate with ICD Z79811 - Long term (current) use of aromatase inhibitors | NA | ||||
| SNF Discharge Rate at DRG | 23.53 | ||||
| SNF Discharge Rate with ICD Z79811 - Long term (current) use of aromatase inhibitors | 27.15 | ||||
| Home Discharge Rate at DRG | 30.67 | ||||
| Home Discharge Rate with ICD Z79811 - Long term (current) use of aromatase inhibitors | 26.58 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 474,314 | ||||
| Total Hospitalizations with ICD Z79811 - Long term (current) use of aromatase inhibitors | 351 | ||||
| DRG Share of Total Hospitalizations | 1.44 | ||||
| % of Total ICD Z79811 - Long term (current) use of aromatase inhibitors in DRG | 1.6 | ||||
| Avg LOS at DRG | 3.53 | ||||
| Avg LOS with ICD Z79811 - Long term (current) use of aromatase inhibitors | 3.41 | ||||
| Readmission Rate at DRG | 18.03 | ||||
| Readmission Rate with ICD Z79811 - Long term (current) use of aromatase inhibitors | 15.04 | ||||
| Unplanned Readmission Rate at DRG | 12.55 | ||||
| Unplanned Readmission Rate with ICD Z79811 - Long term (current) use of aromatase inhibitors | 10.03 | ||||
| Total Medicare payments at DRG | $2,312,733,090 | ||||
| Total Medicare payments with ICD Z79811 - Long term (current) use of aromatase inhibitors | $1,776,517 | ||||
| Total Medicare payment per Day at DRG | $1,380 | ||||
| Total Medicare payment per Day with ICD Z79811 - Long term (current) use of aromatase inhibitors | $1,483 | ||||
| Total Medicare payment per Hospitalization at DRG | $4,876 | ||||
| Total Medicare payment per Hospitalization with ICD Z79811 - Long term (current) use of aromatase inhibitors | $5,061 | ||||
| Total Medicare Charges at DRG | $11,559,952,314 | ||||
| Total Medicare Charges with ICD Z79811 - Long term (current) use of aromatase inhibitors | $8,653,733 | ||||
| Avg Charges at DRG | $24,372 | ||||
| Avg Charges with ICD Z79811 - Long term (current) use of aromatase inhibitors | $24,655 | ||||
| Mortality Rate at DRG | 0.22 | ||||
| Mortality Rate with ICD Z79811 - Long term (current) use of aromatase inhibitors | NA | ||||
| SNF Discharge Rate at DRG | 25.96 | ||||
| SNF Discharge Rate with ICD Z79811 - Long term (current) use of aromatase inhibitors | 26.21 | ||||
| Home Discharge Rate at DRG | 43.58 | ||||
| Home Discharge Rate with ICD Z79811 - Long term (current) use of aromatase inhibitors | 47.01 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 408,103 | ||||
| Total Hospitalizations with ICD Z79811 - Long term (current) use of aromatase inhibitors | 307 | ||||
| DRG Share of Total Hospitalizations | 1.24 | ||||
| % of Total ICD Z79811 - Long term (current) use of aromatase inhibitors in DRG | 1.4 | ||||
| Avg LOS at DRG | 3.52 | ||||
| Avg LOS with ICD Z79811 - Long term (current) use of aromatase inhibitors | 3.44 | ||||
| Readmission Rate at DRG | 17.83 | ||||
| Readmission Rate with ICD Z79811 - Long term (current) use of aromatase inhibitors | 17.99 | ||||
| Unplanned Readmission Rate at DRG | 13.81 | ||||
| Unplanned Readmission Rate with ICD Z79811 - Long term (current) use of aromatase inhibitors | 13.49 | ||||
| Total Medicare payments at DRG | $2,416,862,532 | ||||
| Total Medicare payments with ICD Z79811 - Long term (current) use of aromatase inhibitors | $1,889,423 | ||||
| Total Medicare payment per Day at DRG | $1,682 | ||||
| Total Medicare payment per Day with ICD Z79811 - Long term (current) use of aromatase inhibitors | $1,791 | ||||
| Total Medicare payment per Hospitalization at DRG | $5,922 | ||||
| Total Medicare payment per Hospitalization with ICD Z79811 - Long term (current) use of aromatase inhibitors | $6,154 | ||||
| Total Medicare Charges at DRG | $13,267,744,847 | ||||
| Total Medicare Charges with ICD Z79811 - Long term (current) use of aromatase inhibitors | $9,902,258 | ||||
| Avg Charges at DRG | $32,511 | ||||
| Avg Charges with ICD Z79811 - Long term (current) use of aromatase inhibitors | $32,255 | ||||
| Mortality Rate at DRG | 0.72 | ||||
| Mortality Rate with ICD Z79811 - Long term (current) use of aromatase inhibitors | NA | ||||
| SNF Discharge Rate at DRG | 14.1 | ||||
| SNF Discharge Rate with ICD Z79811 - Long term (current) use of aromatase inhibitors | 11.73 | ||||
| Home Discharge Rate at DRG | 62.97 | ||||
| Home Discharge Rate with ICD Z79811 - Long term (current) use of aromatase inhibitors | 63.19 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 481: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH COMPLICATION OR COMORBIDITY (CC) | DRG 065: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH COMPLICATION OR COMORBIDITY (CC) OR TPA IN 24 HOURS | DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 191: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 292,335 | ||||
| Total Hospitalizations with ICD Z79811 - Long term (current) use of aromatase inhibitors | 239 | ||||
| DRG Share of Total Hospitalizations | 0.89 | ||||
| % of Total ICD Z79811 - Long term (current) use of aromatase inhibitors in DRG | 1.09 | ||||
| Avg LOS at DRG | 2.96 | ||||
| Avg LOS with ICD Z79811 - Long term (current) use of aromatase inhibitors | 2.6 | ||||
| Readmission Rate at DRG | 19.18 | ||||
| Readmission Rate with ICD Z79811 - Long term (current) use of aromatase inhibitors | 17.41 | ||||
| Unplanned Readmission Rate at DRG | 13.96 | ||||
| Unplanned Readmission Rate with ICD Z79811 - Long term (current) use of aromatase inhibitors | 12.05 | ||||
| Total Medicare payments at DRG | $1,347,436,356 | ||||
| Total Medicare payments with ICD Z79811 - Long term (current) use of aromatase inhibitors | $1,063,846 | ||||
| Total Medicare payment per Day at DRG | $1,557 | ||||
| Total Medicare payment per Day with ICD Z79811 - Long term (current) use of aromatase inhibitors | $1,713 | ||||
| Total Medicare payment per Hospitalization at DRG | $4,609 | ||||
| Total Medicare payment per Hospitalization with ICD Z79811 - Long term (current) use of aromatase inhibitors | $4,451 | ||||
| Total Medicare Charges at DRG | $7,385,462,160 | ||||
| Total Medicare Charges with ICD Z79811 - Long term (current) use of aromatase inhibitors | $6,387,220 | ||||
| Avg Charges at DRG | $25,264 | ||||
| Avg Charges with ICD Z79811 - Long term (current) use of aromatase inhibitors | $26,725 | ||||
| Mortality Rate at DRG | 0.57 | ||||
| Mortality Rate with ICD Z79811 - Long term (current) use of aromatase inhibitors | NA | ||||
| SNF Discharge Rate at DRG | 11.55 | ||||
| SNF Discharge Rate with ICD Z79811 - Long term (current) use of aromatase inhibitors | 7.95 | ||||
| Home Discharge Rate at DRG | 63.79 | ||||
| Home Discharge Rate with ICD Z79811 - Long term (current) use of aromatase inhibitors | 66.95 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| UPMC PINNACLE HARRISBURG | 111 S FRONT ST | HARRISBURG | PA | 17101 | 253 |
| UPMC PRESBYTERIAN SHADYSIDE | 200 LOTHROP ST | PITTSBURGH | PA | 15213 | 223 |
| RIVERSIDE METHODIST HOSPITAL | 3535 OLENTANGY RIVER RD | COLUMBUS | OH | 43214 | 207 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. MELISSA D THOMPSON | 4371 NARROW LANE RD | MONTGOMERY | AL | 36116 | 21 |
| Dr. KIRK A KINDSFATER | 2500 E PROSPECT RD | FORT COLLINS | CO | 80525 | 15 |
| Dr. DANA CLARK | 2500 E PROSPECT RD | FORT COLLINS | CO | 80525 | 13 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. MELISSA D THOMPSON | 4371 NARROW LANE RD | MONTGOMERY | AL | 36116 | 33 |
| Dr. ROBERT WILLIAM BERNSTEIN | 300 HALKET ST 1700 | PITTSBURGH | PA | 15213 | 17 |
| Dr. AMANDEEP KAUR DHATT | 200 CARMAN AVE | EAST MEADOW | NY | 11554 | 16 |